Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Hayes

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Journal of Pediatric Surgery|March 1, 1993
Thoracic neuroblastoma: a Pediatric Oncology Group studyG A Adams, S J Shochat, E I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group studyR P Castleberry, A B Cantor, A A Green, et al.
Cancer|April 15, 1992
Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Blood|July 15, 1995
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)J M Rowe, J W Andersen, J J Mazza, et al.
Haematology and Blood Transfusion|January 1, 1989
Use of investigational drugs as initial therapy for childhood solid tumorsW H Meyer, P J Houghton, M E Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988L C Bowman, M L Hancock, V M Santana, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanomaS P Leong, P Enders-Zohr, Y M Zhou, et al.
Human Pathology|May 1, 1993
Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: a report from the Pediatric Oncology GroupV V Joshi, J F Silverman, G Altshuler, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1996
Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Seminars in Oncology|February 1, 1989
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988C B Pratt, E C Douglass, E Etcubanas, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Pediatric Surgery|March 1, 1993
Thoracic neuroblastoma: a Pediatric Oncology Group studyG A Adams, S J Shochat, E I Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group studyR P Castleberry, A B Cantor, A A Green, et al.
Cancer|April 15, 1992
Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Blood|July 15, 1995
A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia: a study of the Eastern Cooperative Oncology Group (E1490)J M Rowe, J W Andersen, J J Mazza, et al.
Haematology and Blood Transfusion|January 1, 1989
Use of investigational drugs as initial therapy for childhood solid tumorsW H Meyer, P J Houghton, M E Horowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: the St Jude Children's Research Hospital experience, 1962 to 1988L C Bowman, M L Hancock, V M Santana, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Recombinant human granulocyte macrophage-colony stimulating factor (rhGM-CSF) and autologous melanoma vaccine mediate tumor regression in patients with metastatic melanomaS P Leong, P Enders-Zohr, Y M Zhou, et al.
Human Pathology|May 1, 1993
Systematization of primary histopathologic and fine-needle aspiration cytologic features and description of unusual histopathologic features of neuroblastic tumors: a report from the Pediatric Oncology GroupV V Joshi, J F Silverman, G Altshuler, et al.
Archives of Pathology & Laboratory Medicine|September 1, 1996
Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology GroupV V Joshi, A B Cantor, G Altshuler, et al.
Seminars in Oncology|February 1, 1989
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988C B Pratt, E C Douglass, E Etcubanas, et al.
Pageof 10